SangStat Medical Corp. has long pursued a disease management model of corporate development. The company's pipeline has reflected this strategy, with products targeted at the full panoply of transplant treatments and diagnostics, from pre-transplant monitoring to acute care products to chronic post-transplant care.

SANG (Menlo Park, Calif.) last week made its first move to implement the strategy on the marketing side with the establishment of The Transplant Pharmacy. This pharmacy management program will cater to the chronic care needs of transplant recipients.